Prevention of cervical cancer

References

• BF Ferlay, P Pisani, DM Parkin. Globocan 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. 2004; IARC Press: Lyon.
   Google Scholar
• DM Parkin, SL Whelan, J Ferlay, L Teo, DB Thomas. Cancer Incidence in Five Continents, Vol VIII. IARC Scientific Publications No. 155. 2002; IARC: Lyon.
   Google Scholar
• Cancer Registry of South Africa, Annual Report 1987.
   Google Scholar
• F Sitas, J Madhoo, J Wessie. Incidence of Histologically Diagnosed Cancer in South Africa, 1993–1995, National Cancer Registry of South Africa. 1998; South African Institute of Medical Research: Johannesburg.
   Google Scholar
• N Mqoqi, P Kellet, F Sitas, M Jula. Incidence of Histologically Diagnosed cancer in South Africa, 1998–1999. National Cancer Registry of South Africa. December. 2004; National Health Laboratory Service: Johannesburg.
   Google Scholar
• ARP Walker, PM Michelow, BF Walker. Cervix cancer in African women in Durban, South Africa. International Journal of Gynecology and Obstetrics. 2002 Apr 30; 45–46.
   Web of Science ®Google Scholar
• N Munoz, FX Bosch, S de Sanjose, R Herrero, X Castellsague, KV Shah. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 348: 2003; 518–527.
   PubMed Web of Science ®Google Scholar
• GM Clifford, JS Smith, M Plummer, N Munoz, S Franceschi. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. British Journal of Cancer. 88: 2003; 63–73. URL: http://www.nature.com/bjc/journal/v88/n1/abs/6600688a.html
   PubMed Web of Science ®Google Scholar
• N Munoz, S Franceschi, C Bosetti, V Moreno, R Herrero, JS Smith. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 359(9312): 2002 Mar 30; 1093–1101.
   PubMed Web of Science ®Google Scholar
• International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13, 541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 118(6): 2006; 1481–1495. URL: http://www3.interscience.wiley.com/cgi-bin/abstract/112099381/ABSTRACT
   Web of Science ®Google Scholar
• V Moreno, FX Bosch, N Munoz, CJ Meijer, KV Shah, JMM Walboomers. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study. Lancet. 359(9312): 2002 Mar; 1085–1092. URL: http://image.thelancet.com/extras/01art3030web.pdf
   PubMed Web of Science ®Google Scholar
• JS Smith, R Herrero, C Bosetti. Herpes Simplex Virus-2 as a human pappilomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 94(21): 2002; 1604–1613.
   PubMedGoogle Scholar
• KL Wallin, F Wiklun, T Luostarinen, T Angstrom, T Anttila, F Bergman. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer. 101(4): 2002 Oct 1; 371–374. URL: http://www3.interscience.wiley.com/cgi-bin/abstract/97518948/ABSTRACT?CRETRY=1&SRETRY=0
   PubMed Web of Science ®Google Scholar
• F Sitas, R Pacella-Norman, H Carrara, M Patel, P Ruff, R Sur. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer. 88(3): 2000; 489–492. URL: http://www3.interscience.wiley.com/cgi-bin/abstract/73504895/ABSTRACT
   Web of Science ®Google Scholar
• P Lomalisa, T Smith, F Guidozzi. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol. 77(3): 2000 Jun; 460–463.
   PubMed Web of Science ®Google Scholar
• M Moodley, S Mould. Invasive cervical cancer and human immunodeficiency virus (HIV) infection in KwaZulu-Natal, South Africa. J Obstet Gynaecol. 25: 2005; 706–710.
   Google Scholar
• T Harris, RD Burke, JM Palefsky, LS Massad, J Yon Bang, K Anastos. Incidence of Cervical Squamous Intraepithelial Lesions Associated with HIV Serostatus, CD4 Cell counts, and Human Papillomavirus Test Results. JAMA. 293: 2005; 1471–1476.
   PubMed Web of Science ®Google Scholar
• J Moodley, M Hoffman, H Carrara, B Allan, D Cooper, L Rosenberg. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: A casecontrol study. BMC Cancer. 6: 2006; 135–141.
   PubMed Web of Science ®Google Scholar
• LE Manhart, LA Koutsky. Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia? A Meta-Analysis. Sex Trans Dis. 29: 2002; 725–735.
   PubMed Web of Science ®Google Scholar
• LA Koutsky, KA Ault, CM Wheeler, DR Brown, E Barr, F Alvarez. A controlled trial of a human papillomavirus type-16 vaccine. N Engl J Med. 347: 2002; 1645–1651.
   PubMed Web of Science ®Google Scholar
• C Mao, LA Koutsky, KA Ault, CM Wheeler, DR Brown, DJ Wiley. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 107(1): 2006; 18–27. URL: http://www.ob-gyn.ca/pdf/Suggested%20Readings/ForMay09_BadawiHPV_Vaccine.pdf
   PubMed Web of Science ®Google Scholar
• DM Harper, EL Franco, C Wheeler, DG Ferris, D Jenkins, A Schuind. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet. 364(9447): 2004 Nov; 1757–1765.
   PubMed Web of Science ®Google Scholar
• DM Harper, EL Franco, CM Wheeler, A Moscicki, CM Roteli-Martins, D Jenkins. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet. 367(9518): 2006 April; 1247–1255.
   PubMed Web of Science ®Google Scholar
• LL Villa, RL Costa, CA Petta, RP Andrade, KA Ault, AR Giuliana. Prophylactic quadrivalent human papillomavirus types 6, 11, 16, and 18 L1 virus-like particle vaccine in young women: a randomized doubleblind placebo-controlled multicentre phase 11 efficacy trial. Lancet Oncol. 6(5): 2005 May; 271–278.
   PubMed Web of Science ®Google Scholar
• N Munoz, FX Bosch, X Castellsague, M Diaz, S de Sanjose, D Hammounda. Against which Human Papillomaviurs types shall we vaccinate and screen? The International Perspective. Int J Cancer. 111: 2004; 278–285.
   PubMed Web of Science ®Google Scholar
• Summary Chapter: IARC Working Group on Cervical Cancer Screening. M Hakama, AB Miller, NE Day. Screening for Cancer of the Uterine Cervix. 1986; International Agency for Research on Cancer: Lyon, 133–142.
   Google Scholar
• E Laara, NE Day, M Hakama. Trends in Mortality from Cervical Cancer in the Nordic Countries: Association with organized screening programmes. Lancet. 1987 May 30; 247–249.
   Web of Science ®Google Scholar
• IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: the duration of low risk after negative result of cervical cytology and its implication for screening policies. Br Med J. 293: 1986; 659–664.
   PubMedGoogle Scholar
• M Hakama, K Louhivuori. A screening programme for cervical cancer that worked. Cancer surveys. 17(3): 1988; 403–416.
   Google Scholar
• S Fonn, B Bloch, M Mabina, S Carpenter, H Cronje, C Maise. Prevalence of pre-cancerous lesions and cervical cancer in South Africa – a multicentre study. S Afr Med J. 92(2): 2002 Feb; 148–156.
   PubMed Web of Science ®Google Scholar
• S Fonn, B Klugman, K Dehaeck. Towards a National Screening Policy for Cancer of the Cervix in South Africa. Paper no. 31. 1993; The Centre for Health Policy, Department of Community Health, Medical School, University of Witswatersrand: Johannesburg.
   Google Scholar
• Baillie R. Cervical Cytology Screening: Towards the Development of a Rational Policy for the Western Cape, South Africa. Doctoral Thesis. Department of Community Health. University of Cape Town; December 1994.
   Google Scholar
• HS Cronje, MD Trumpelmann, PD Divall, LL Scott, BD Middlecote, JI De Wet. Cervical cytological services in the Orange Free State. Demographic Characteristics. S Afr Med J. 76: 1989; 116.
   Web of Science ®Google Scholar
• MJ Heysteck, ET de Jonge, HP Meyer, BG Lindeque. Screening for cervical neoplasia in Mamelodi – lessons from an unscreened population. S Afr Med J. 85(11): 1995 Nov; 1180–1182.
   Web of Science ®Google Scholar
• Leiman Gladwyn. ‘Project Screen Soweto’ – A planned cervical cancer screening programme in a high-risk population. The S Afr Journal of Epidemiology and Infection. 2: 1987; 61–68.
   Google Scholar
• S Emdon, U Gerard, R Jones. Knowledge about and utilisation of facilities for cervical smears among black women in Johannesburg. S Afr Med J. 65: 1984; 289–290.
   PubMed Web of Science ®Google Scholar
• N Smith, J Moodley, M Hoffman. Challenges to cervical cancer screening in the Western Cape province. S Afr Med J. 93(1): 2003 Jan; 32–35.
   Web of Science ®Google Scholar
• S Fonn. Human resource requirements for introducing cervical screening – who do we need where?. S Afr Med J. 93(10): 2003; 901–903.
   Google Scholar
• P Michelow, M Dubb. The implementation of a national cervical screening programme: are our cytology laboratories up to the challenge?. The S Afr Journal of Epidemiology and Infection. 18: 2003; 38–41.
   Google Scholar
• L Denny, L Kuhn, A Pollack, TC Wright Jr. Direct visual inspection for cervical cancer screening. Cancer. 94(16): 2002; 1699–1707. URL: http://www3.interscience.wiley.com/cgi-bin/abstract/91016204/ABSTRACT
   Web of Science ®Google Scholar
• R Sankaranarayanan, L Gaffikin, M Jacob, J Sellors, S Robles. A Critical Assessment of Screening Methods for Cervical Neoplasia. Int J Gynaecol Obstet. 89 Suppl 2: 2005 May; S4–S12.
   Web of Science ®Google Scholar
• J Cuzick, C Clavel, KU Petry, CJ Meijer, H Hoyer, S Ratnam. Overview of the the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 119(5): 2006 Sep; 1095–1101.
   PubMed Web of Science ®Google Scholar
• L Denny, L Kuhn, M De Souza, AE Pollack, W Dupree, TC Wright. Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings. A Randomized Controlled Trial. JAMA. 294: 2005; 2173–2181. URL: http://jama.ama-assn.org/cgi/content/abstract/294/17/2173
   PubMed Web of Science ®Google Scholar
• L Gaffikin, PD Blumenthal, M Emerson, K Limpaphayom, Royal Thai College of Obstetricians and Gynaecologist (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand; a demonstration project. Lancet. 361(9360): 2003 Mar; 814–820.
   Web of Science ®Google Scholar